"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
Sodium Acetate Injection, USP 40 mEq is indicated as a source of sodium, for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.
DOSAGE AND ADMINISTRATION
Sodium Acetate (sodium acetate (sodium acetate (sodium acetate injection) injection) injection) Injection, USP 40 mEq is administered intravenously only after dilution in a larger volume of fluid. The dose and rate of administration are dependent upon the individual needs of the patient. Serum sodium should be monitored as a guide to dosage. Using aseptic technique, all or part of the contents of one or more vials may be added to other intravenous fluids to provide any desired number of milliequivalents (mEq) of sodium (Na+) with an equal number of acetate (CH3COO-).
Sodium Acetate (sodium acetate (sodium acetate (sodium acetate injection) injection) injection) Injection, USP 40 mEq (2 mEq/mL) is supplied in a 20 mL partial-fill single-dose Plastic Vial (List No. 7299). Each vial is partially filled to provide air space for complete vacuum withdrawal of the contents into the I.V. container. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Rev: October, 2004. HOSPIRA, INC., LAKE FOREST, IL 60045 USAThis monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/19/2009
Additional Sodium Acetate Information
Report Problems to the Food and Drug Administration
Find out what women really need.